dapagliflozin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Inhibits STING1
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“Dapagliflozin effectively inhibited STING activation and suppressed inflammatory cytokines production in mutant TECs.”
Quoted verbatim from Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells.. - Study
- in vitro · not in humans
- Population
- tubular epithelial cells from Col4a3-mutant Alport syndrome mice
Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells.2026PMID:41499173Permalink
Keep reading
- Everything the graph holds on dapagliflozin
- Every compound studied against STING1
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PNCPQRPPWBY1CSYV0D9V4P